Coronavirus disease-2019: is fever an adequate screening for the returning travelers?
Identifieur interne : 000572 ( PubMed/Curation ); précédent : 000571; suivant : 000573Coronavirus disease-2019: is fever an adequate screening for the returning travelers?
Auteurs : George M. Bwire [Tanzanie] ; Linda S. Paulo [Tanzanie]Source :
- Tropical medicine and health [ 1348-8945 ] ; 2020.
Abstract
On Thursday, 30 January 2020, World Health Organization declared Coronavirus disease-2019 (COVID-2019) a Public Health Emergency of International Concern. Since its identification in late December 2019 in Wuhan, Hubei Province, People's Republic of China, the number of cases imported into other countries is increasing, and the epidemiological map is changing rapidly. On the other hand, body temperature screening (fever) is the major test performed at points of entry, i.e., airports, in the returning travelers in most of the countries with limited resources. However, the recent report on asymptomatic contact transmission of COVID-19 and travelers who passed the symptoms-based screening and tested positive for COVID-19 using reverse transcription polymerase chain reaction (RT-PCR) challenges this approach as body temperature screening may miss travelers incubating the disease or travelers concealing fever during travel. On this note, travel restrictions to and from high risk areas and/or 14 days quarantine of travelers coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19.
DOI: 10.1186/s41182-020-00201-2
PubMed: 32165854
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000572
Links to Exploration step
pubmed:32165854Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus disease-2019: is fever an adequate screening for the returning travelers?</title><author><name sortKey="Bwire, George M" sort="Bwire, George M" uniqKey="Bwire G" first="George M" last="Bwire">George M. Bwire</name><affiliation wicri:level="1"><nlm:affiliation>1School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</nlm:affiliation><country xml:lang="fr">Tanzanie</country><wicri:regionArea>1School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam</wicri:regionArea></affiliation></author><author><name sortKey="Paulo, Linda S" sort="Paulo, Linda S" uniqKey="Paulo L" first="Linda S" last="Paulo">Linda S. Paulo</name><affiliation wicri:level="1"><nlm:affiliation>2School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</nlm:affiliation><country xml:lang="fr">Tanzanie</country><wicri:regionArea>2School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32165854</idno><idno type="pmid">32165854</idno><idno type="doi">10.1186/s41182-020-00201-2</idno><idno type="wicri:Area/PubMed/Corpus">000572</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000572</idno><idno type="wicri:Area/PubMed/Curation">000572</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000572</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus disease-2019: is fever an adequate screening for the returning travelers?</title><author><name sortKey="Bwire, George M" sort="Bwire, George M" uniqKey="Bwire G" first="George M" last="Bwire">George M. Bwire</name><affiliation wicri:level="1"><nlm:affiliation>1School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</nlm:affiliation><country xml:lang="fr">Tanzanie</country><wicri:regionArea>1School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam</wicri:regionArea></affiliation></author><author><name sortKey="Paulo, Linda S" sort="Paulo, Linda S" uniqKey="Paulo L" first="Linda S" last="Paulo">Linda S. Paulo</name><affiliation wicri:level="1"><nlm:affiliation>2School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</nlm:affiliation><country xml:lang="fr">Tanzanie</country><wicri:regionArea>2School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam</wicri:regionArea></affiliation></author></analytic><series><title level="j">Tropical medicine and health</title><idno type="ISSN">1348-8945</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">On Thursday, 30 January 2020, World Health Organization declared Coronavirus disease-2019 (COVID-2019) a Public Health Emergency of International Concern. Since its identification in late December 2019 in Wuhan, Hubei Province, People's Republic of China, the number of cases imported into other countries is increasing, and the epidemiological map is changing rapidly. On the other hand, body temperature screening (fever) is the major test performed at points of entry, i.e., airports, in the returning travelers in most of the countries with limited resources. However, the recent report on asymptomatic contact transmission of COVID-19 and travelers who passed the symptoms-based screening and tested positive for COVID-19 using reverse transcription polymerase chain reaction (RT-PCR) challenges this approach as body temperature screening may miss travelers incubating the disease or travelers concealing fever during travel. On this note, travel restrictions to and from high risk areas and/or 14 days quarantine of travelers coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32165854</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1348-8945</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Tropical medicine and health</Title><ISOAbbreviation>Trop Med Health</ISOAbbreviation></Journal><ArticleTitle>Coronavirus disease-2019: is fever an adequate screening for the returning travelers?</ArticleTitle><Pagination><MedlinePgn>14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41182-020-00201-2</ELocationID><Abstract><AbstractText>On Thursday, 30 January 2020, World Health Organization declared Coronavirus disease-2019 (COVID-2019) a Public Health Emergency of International Concern. Since its identification in late December 2019 in Wuhan, Hubei Province, People's Republic of China, the number of cases imported into other countries is increasing, and the epidemiological map is changing rapidly. On the other hand, body temperature screening (fever) is the major test performed at points of entry, i.e., airports, in the returning travelers in most of the countries with limited resources. However, the recent report on asymptomatic contact transmission of COVID-19 and travelers who passed the symptoms-based screening and tested positive for COVID-19 using reverse transcription polymerase chain reaction (RT-PCR) challenges this approach as body temperature screening may miss travelers incubating the disease or travelers concealing fever during travel. On this note, travel restrictions to and from high risk areas and/or 14 days quarantine of travelers coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19.</AbstractText><CopyrightInformation>© The Author(s) 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bwire</LastName><ForeName>George M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>1School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</Affiliation><Identifier Source="GRID">grid.25867.3e</Identifier><Identifier Source="ISNI">0000 0001 1481 7466</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulo</LastName><ForeName>Linda S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>2School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.</Affiliation><Identifier Source="GRID">grid.25867.3e</Identifier><Identifier Source="ISNI">0000 0001 1481 7466</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Trop Med Health</MedlineTA><NlmUniqueID>101215093</NlmUniqueID><ISSNLinking>1348-8945</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Fever</Keyword><Keyword MajorTopicYN="N">Returning travelers</Keyword><Keyword MajorTopicYN="N">Temperature screening</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32165854</ArticleId><ArticleId IdType="doi">10.1186/s41182-020-00201-2</ArticleId><ArticleId IdType="pii">201</ArticleId><ArticleId IdType="pmc">PMC7061485</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2017 Feb 9;376(6):548-560</Citation><ArticleIdList><ArticleId IdType="pubmed">28177860</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2010 Aug;14(8):e693-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20656647</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Feb 18;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32069388</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation><ArticleIdList><ArticleId IdType="pubmed">32003551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000572 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000572 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32165854
|texte= Coronavirus disease-2019: is fever an adequate screening for the returning travelers?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32165854" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |